Terms of Use

Terms of Use

The indicated use is for treatment of ocular damage and disease using photobiomodulation, including inhibition of inflammatory mediators, edema or drusen deposition, improvement of wound healing following ocular trauma or surgery, and increase in visual acuity and contrast sensitivity in patients with degenerative diseases such as dry age-related macular degeneration.

Now’s the Time to Talk

Request time with one of our representatives to learn more about Valeda.

Contact Us
Valeda
LumiThera & Valeda have now been acquired by Alcon - You can learn more about Alcon here and more about how Alcon handles Personal Information at: Alcon Privacy Notice